Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma

European Journal of Cancer Prevention

Volumn 22, Issue 1, 2013, Pages 77-82

  Deng, Qian ^a,c   Zheng, Tongzhang ^c   Lan, Qing ^d   Lan, Yajia ^a   Holford, Theodore ^c   Chen, Yingtai ^b   Dai, Min ^b   Leaderer, Brian ^c   Boyle, Peter ^e   Chanock, Stephen J ^d   Rothman, Nathaniel ^c   Zhang, Yawei ^c  

^a SICHUAN UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c YALE UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

immune genes; non Hodgkin lymphoma; occupational exposure; single nucleotide polymorphism; solvents

Indexed keywords

INTERLEUKIN 10; ORGANIC SOLVENT;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; IMMUNE GENE; IMMUNOREGULATION; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OCCUPATIONAL EXPOSURE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SOLVENTS; YOUNG ADULT;

EID: 84871020293     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328354d2c1     Document Type: Article

References (40)

1. Aggarwal BB (2003). Signalling pathways of the TNF superfamily: A doubleedged sword. Nat Rev Immunol 3:745-756
2. Alexander DD, Wagner ME (2010). Benzene exposure and non-Hodgkin lymphoma: A meta-analysis of epidemiologic studies. J Occup Environ Med 52:169-189
3. Bailey DP, Kashyap M, Bouton LA, Murray PJ, Ryan JJ (2006). Interleukin-10 induces apoptosis in developing mast cells and macrophages. J Leukoc Biol 80:581-589
4. Barry KH, Zhang Y, Lan Q, Zahm SH, Holford TR, Leaderer B, et al. (2010). Genetic variation in metabolic genes, occupational solvent exposure, and risk of non-Hodgkin lymphoma. Am J Epidemiol 173:404-413
5. Benjamini YHY (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 57:289-300
6. Brandao MM, Rego MA, Pugliese L, Clarencio J, Bastos CM, Ferreira J, et al. (2005). Phenotype analysis of lymphocytes of workers with chronic benzene poisoning. Immunol Lett 101:65-70
7. Breen EC, Boscardin WJ, Detels R, Jacobson LP, Smith MW, O'Brien SJ, et al. (2003). Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter 592 C/C genotype. Clin Immunol 109:119-129
8. Cartwright RA, McKinney PA, O'Brien C, Richards ID, Roberts B, Lauder I, et al. (1988). Non-Hodgkin's lymphoma: Case control epidemiological study in Yorkshire. Leuk Res 12:81-88
9. Colt JS, Rothman N, Severson RK, Hartge P, Cerhan JR, Chatterjee N, et al. (2009). Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood 113:1899-1905
10. Dosemeci M, Cocco P, Gomez M, Stewart PA, Heineman EF (1994). Effects of three features of a job-exposure matrix on risk estimates. Epidemiology 5:124-127
11. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP (2001). Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166:3915-3922
12. Hochberg YBY (1990). More powerful procedures for multiple significance testing. Stat Med 9:811-818
13. Hori S, Nomura T, Sakaguchi S (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-1061
14. Jaffe ESSH, Vardiman JW (2001). World Health Organization classification of tumors: Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press
15. Kato I, Koenig KL, Watanabe-Meserve H, Baptiste MS, Lillquist PP, Frizzera G, et al. (2005). Personal and occupational exposure to organic solvents and risk of non-Hodgkin's lymphoma (NHL) in women (United States). Cancer Causes Control 16:1215-1224
16. Khatri VP, Caligiuri MA (1998). A review of the association between interleukin-10 and human B-cell malignancies. Cancer Immunol Immunother 46:239-244
17. La Vecchia C, Negri E, Franceschi S (1992). Medical history and the risk of non-Hodgkin's lymphomas. Cancer Epidemiol Biomarkers Prev 1:533-536
18. Lan Q, Zheng T, Rothman N, Zhang Y,Wang SS, Shen M, et al. (2006). Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 107:4101-4108
19. Lange A, Smolik R, Zatonski W, Szymanska J (1973). Serum immunoglobulin levels in workers exposed to benzene, toluene and xylene. Int Arch Arbeitsmed 31:37-44
20. Lech-Maranda E, Baseggio L, Bienvenu J, Charlot C, Berger F, Rigal D, et al. (2004). Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 103:3529-3534
21. Mandel JH, Kelsh MA, Mink PJ, Alexander DD, Kalmes RM, Weingart M, et al. (2006). Occupational trichloroethylene exposure and non-Hodgkin's lymphoma: A meta-analysis and review. Occup Environ Med 63:597-607
22. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M (2005). Epidemiology of non-Hodgkin's lymphoma (NHL): Trends, geographic distribution, and etiology. Ann Hematol 84:1-12
23. Office of Management and Budget (1987). Standard Industrial Classification Manual. Washington, DC: US Government Printing Office
24. Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, Turner J, et al. (2007). Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: Findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 28:704-712
25. Purdue MP, Bakke B, Stewart P, De Roos AJ, Schenk M, Lynch CF, et al. (2011). A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma. Environ Health Perspect 119:232-238
26. Rego MA, Sousa CS, Kato M, de Carvalho AB, Loomis D, Carvalho FM (2002). Non-Hodgkin's lymphomas and organic solvents. J Occup Environ Med 44:874-881
27. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, et al. (2006). Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: A report from the InterLymph Consortium. Lancet Oncol 7:27-38
28. Seidler A, Mohner M, Berger J, Mester B, Deeg E, Elsner G, et al. (2007). Solvent exposure and malignant lymphoma: A population-based case-control study in Germany. J Occup Med Toxicol 2:2
29. Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjose S, Hughes AM, et al. (2010). Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 171:267-276
30. Smith PR, Lickiss JN (1980). Benzene and lymphomas. Lancet 1:719
31. Tranah GJ, Holly EA, Bracci PM (2009). Solvent exposure and non-Hodgkin lymphoma: no risk in a population-based study in the San Francisco Bay area. Cancer Epidemiol Biomarkers Prev 18:3130-3132
32. US Department of Commerce (1980). Standard Occupational Classification Manual. Washington, DC: US Government Printing Office
33. Vianna NJ, Polan A (1979). Lymphomas and occupational benzene exposure. Lancet 1:1394-1395
34. Vineis P, Miligi L, Costantini AS (2007). Exposure to solvents and risk of non-Hodgkin lymphoma: Clues on putative mechanisms. Cancer Epidemiol Biomarkers Prev 16:381-384
35. Wang R, Zhang Y, Lan Q, Holford TR, Leaderer B, Zahm SH, et al. (2009). Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol 169:176-185
36. Wieczorek S, Hellmich B, Arning L, Moosig F, Lamprecht P, Gross WL, et al. (2008). Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis. Arthritis Rheum 58: 1839-1848
37. Wong O, Raabe GK (2000). Non-Hodgkin's lymphoma and exposure to benzene in a multinational cohort of more than 308,000 petroleum workers, 1937 to 1996. J Occup Environ Med 42:554-568
38. Zeman K, Tchorzewski H, Baj Z, Nowak Z, Majewska E, Pokoca L, et al. (1990). The effects of occupational exposure to hydrocarbons on some immune parameters of workers of the phenol division of a petrochemical plant. Pol J Occup Med 3:399-407
39. Zhang YW, Holford TR, Leaderer B, Boyle P, Zahm SH, Flynn S, et al. (2004). Hair-coloring product use and risk of non-Hodgkin's lymphoma: A populationbased case-control study in Connecticut. Am J Epidemiol 159:148-154
40. Zhao Y, Krishnadasan A, Kennedy N, Morgenstern H, Ritz B (2005). Estimated effects of solvents and mineral oils on cancer incidence and mortality in a cohort of aerospace workers. Am J Ind Med 48:249-258